Sabra Health Care REIT (SBRA) Expected to Announce Earnings on Monday

Sabra Health Care REIT (NASDAQ:SBRA) is expected to be releasing its Q1 2025 earnings data after the market closes on Monday, May 5th. Analysts expect Sabra Health Care REIT to post earnings of $0.36 per share and revenue of $180.23 million for the quarter. Sabra Health Care REIT has set its FY 2025 guidance at 1.430-1.460 EPS.

Sabra Health Care REIT (NASDAQ:SBRA) last issued its quarterly earnings data on Wednesday, February 19th. The real estate investment trust reported $0.36 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.36. The company had revenue of $182.35 million for the quarter, compared to analyst estimates of $178.01 million. Sabra Health Care REIT had a return on equity of 4.60% and a net margin of 18.02%. On average, analysts expect Sabra Health Care REIT to post $1 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Sabra Health Care REIT Stock Down 1.1 %

SBRA opened at $17.42 on Friday. Sabra Health Care REIT has a 12 month low of $13.87 and a 12 month high of $20.03. The company has a debt-to-equity ratio of 0.88, a current ratio of 4.32 and a quick ratio of 4.16. The stock has a market capitalization of $4.14 billion, a P/E ratio of 32.87, a P/E/G ratio of 1.97 and a beta of 0.93. The business has a 50 day simple moving average of $17.27 and a 200-day simple moving average of $17.51.

Sabra Health Care REIT Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, February 28th. Shareholders of record on Friday, February 14th were issued a $0.30 dividend. The ex-dividend date was Friday, February 14th. This represents a $1.20 dividend on an annualized basis and a yield of 6.89%. Sabra Health Care REIT’s dividend payout ratio (DPR) is 226.42%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on the company. Truist Financial raised their price target on Sabra Health Care REIT from $17.00 to $18.00 and gave the company a “hold” rating in a research report on Tuesday, March 18th. Citizens Jmp upgraded Sabra Health Care REIT from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, January 7th. Finally, JMP Securities raised shares of Sabra Health Care REIT from a “market perform” rating to an “outperform” rating and set a $20.00 price target on the stock in a report on Tuesday, January 7th. Three equities research analysts have rated the stock with a hold rating, three have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $19.33.

About Sabra Health Care REIT

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.